[1]
Dr. Noynika Shukla, “AI-Driven Precision Targeting Beyond KRAS: Daraxonrasib, Pan-RAS(ON) Inhibition, and Emerging Predictive Biomarkers in RAS-Driven Cancers ”, IJESH, vol. 15, no. 2, pp. 500–512, Jun. 2025.